Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aprotinin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Aprotinin adverse reaction |
Causative agent |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Allergy to aprotinin (finding) |
Causative agent |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Aprotinin [pancreatitis] [see chapter b] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Trasylol injection 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Trasylol injection 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Aprotinin injection 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Aprotinin injection 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Aprotinin [fibrinolytic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
aprotinin 10.000 IE/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Aprotinin injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Trasylol injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
aprotinin 10.000 kIU/ml injektionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
aprotinin 10.000 kiu/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Some |
|
Allergy to aprotinin (finding) |
Causative agent |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Product containing only aprotinin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Aprotinin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Product containing only aprotinin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Aprotinin 1.4 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Aprotinin 1.4 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |
Aprotinin therapy |
Direct substance |
True |
Aprotinin (substance) |
Inferred relationship |
Some |
1 |